SUBSCRIBE
Drivetime Radio

Drivetime Specialty is a free educational audio program covering a range of topics relevant to various medical specialists & physicians. Listen to our experienced medical broadcasters, moderating engaging discussions with leading experts.

Current programs include:

  • NEW Dentist – hosted by Dr Patrick Meaney
  • Epilepsy – hosted by Prof Mark Cook, Neurologist, Melbourne
  • Endocrinology – hosted by Prof Rod Baber, Obstetrician & Gynaecologist, Sydney
  • Neurology – hosted by Prof Mark Cook, Neurologist, Melbourne
  • Ophthalmology – hosted by Prof Paul Mitchell, Ophthalmologist, Sydney
  • Psychiatry – hosted by Prof Malcolm Hopwood, Psychiatrist, Melbourne
  • Respiratory – hosted by Prof John Upham, Respiratory Physician, Brisbane

More disciplines coming soon……

Podcasts are available for each series – providing a time efficient form of communication that’s convenient and easy to consume. Click here for podcast download instructions

You can also listen online – either search by your area of interest to filter interviews relevant to you, or if you are logged in you can click on specific programs below.

Interviews are provided exclusively for Australian healthcare professionals. Subscribe for free today to access all programs.

Search Interviews

By area of interest:

Specialty Interviews

Res.6.1Results from the Australian Mepolizumab Registry in Severe Asthma (22 mins)
00:00
Preview
10 seconds
Show more information

Respiratory: ‘Real world evidence’ is a bit of a buzz word in research circles at the moment. Increasingly this type of evidence is being used to inform both regulatory and payor decision-making. But what does it mean clinically? And should we be paying attention? In this interview we discuss real world evidence, with a particular focus on severe asthma biologics.
23-minute listen

The Australian Mepolizumab Registry is an investigator-initiated and managed study funded through the GlaxoSmithKline Investigator-Sponsored Studies program

Hosted by

Professor John Upham

Interviewees

  • Prof. Peter Wark, Senior Staff Specialist in Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSWProf. Peter Wark, Senior Staff Specialist in Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW
Res.6.2At home administration options for severe asthma patients (15 mins)
00:00
Preview
10 seconds
Show more information

Respiratory: Up until now, the treatment for severe asthma with biologic medications has been predominantly administered by healthcare practitioners. In this interview, we’ll explore the paradigm shift towards patients self-administering biologic treatments. How do we choose patients who are suitable for self-administration? How might empowering patients to self-administer treatment reduce current barriers faced by patients and improve convenience?
15-minute listen

Hosted by

Professor John Upham

Interviewees

  • Dr John Blakey, Associate Professor, the Curtin Medical School, Consultant Respiratory Physician, Sir Charles Gardner Hospital, Perth Dr John Blakey, Associate Professor, the Curtin Medical School, Consultant Respiratory Physician, Sir Charles Gardner Hospital, Perth 
Epi.5Epilepsy in adolescents – A critical time (23 mins)
00:00
Preview
10 seconds
Show more information

Epilepsy: Epilepsy is commonly diagnosed in adolescence, affecting approximately 1% of children aged 14 to 16 years. At a time of critical intellectual, physical, hormonal and social development, epilepsy can have a significant effect on the teenager’s lifestyle. Choosing the right anti-epileptic drug from the start can have significant benefits to teenagers, enabling them to gain the necessary independence and self-empowerment to mature through adolescence.
23-minute listen

Hosted by

Professor Mark Cook

Interviewees

  • Dr John Lawson, Paediatric Neurologist and Epileptologist, Sydney Children’s Hospital, RandwickDr John Lawson, Paediatric Neurologist and Epileptologist, Sydney Children’s Hospital, Randwick
Epi.6The big questions in epilepsy and genetics (30 mins)
00:00
Preview
10 seconds
Show more information

Epilepsy: What are the most significant understandings in genetics that have happened over the last few years, and what have been the big breakthroughs? In this interview we present a remarkable view of this incredibly wide ranging field, where there have been so many dramatic developments. We provide a valuable background and some practical advice about what we can say to patients, and how to approach screening issues.
30-minute listen

Hosted by

Professor Mark Cook

Interviewees

  • Prof. Sam Berkovic, Head of the Epilepsy Centre, the Austin Hospital, MelbourneProf. Sam Berkovic, Head of the Epilepsy Centre, the Austin Hospital, Melbourne
Den.1.1Dental Update: ONJ and osteoporosis (28 mins)
00:00
Preview
10 seconds
Show more information

Dentist: This update for Dentists, explains the latest evidence and recommendations for minimising the risk for ONJ and maintaining fracture protection in patients being treated for osteoporosis.

Hosted by

Dr Patrick Meaney

Interviewees

  • Dr Christian Girgis, Endocrinologist,  The Royal North Shore Hospital, SydneyDr Christian Girgis, Endocrinologist, The Royal North Shore Hospital, Sydney
Psy.6.1The importance of treating the constellation of major depressive disorder symptoms (19 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry: In this interview we discuss major depressive disorder (MDD) in all its complexity and the challenge it presents to us. MDD not only impacts a patient’s mood, but also their social lives, their professional lives and of course their family and other relationships. We discuss these issues in the setting of treatment choices and the importance of identifying and treating the constellation of MDD symptoms in practice.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Prof. John Tiller, University of Melbourne and Albert Road Clinic, MelbourneProf. John Tiller, University of Melbourne and Albert Road Clinic, Melbourne
Psy.6.2Treating schizophrenia and involving patients in treatment decisions (19 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry: We will often identify psychotic symptoms and be responsible for considering antipsychotic therapy in patients who are treatment naïve. In this interview we look at the considerations that are important when we are contemplating treatment choice.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Dr Manoj Ravindran, Private Psychiatrist, North West Private Mental Health, Burnie, Tasmania Dr Manoj Ravindran, Private Psychiatrist, North West Private Mental Health, Burnie, Tasmania
Psy.5.1Considering long-term goals while managing the acute phase of schizophrenia (21 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry: Conventionally during the acute phase of psychosis, we’ve tended to focus on short-term treatment of intense positive symptoms, hostility and agitation, and may not consider long-term treatment goals such as the improvement of negative symptoms and cognitive deficits the way we might like. In this interview, we’re talking about the importance of considering long-term treatment goals of schizophrenia when treating patients with psychosis in the acute phase.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • A/Prof. Matthew Warden, Psychiatrist, St Vincent’s Hospital, Melbourne, AustraliaA/Prof. Matthew Warden, Psychiatrist, St Vincent’s Hospital, Melbourne, Australia
Psy.5.2Strategies for ‘the conversation’ around long-acting injectable antipsychotics in patients with schizophrenia (20 mins)
00:00
Preview
10 seconds
Show more information

NEW Psychiatry. Schizophrenia is a treatable condition, we have good treatments and treatment does lead to remission if we deliver the appropriate treatment. In this interview we discuss the biggest challenges that we face as a clinicians, particularly in patients with an established diagnosis of schizophrenia, as well as patient priorities and how we can balance trust in the relationship while making sure that they have the best outcome.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • A/Prof. Mark Taylor, Psychiatrist, Toowong Specialist Clinic, BrisbaneA/Prof. Mark Taylor, Psychiatrist, Toowong Specialist Clinic, Brisbane
Psy.5.3Choice of discharge antipsychotic – A community psychiatrist’s view (21 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry. Schizophrenia is a cyclical disease with approximately 94% of patients experiencing multiple episodes of psychosis. During periods of acute psychosis, patients may require hospitalisation, however eventually they will be discharged, and it’s during this period that transition care arrangements are very important. In this interview we discuss managing patients as they move from inpatient hospitalisation, back to community care.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Dr Rebecca Roma, Community Psychiatrist, Pittsburgh, USADr Rebecca Roma, Community Psychiatrist, Pittsburgh, USA

Search Interviews

By area of interest:

Exclusively for Australian healthcare professionals
×

Tap the share icon ios share icon and select 'Add to Home Screen' to add the site to your home screen for quick access!